Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: CDER reorganization

This article was originally published in The Tan Sheet

Executive Summary

CDER reorganization: ODE 5 Director Michael Weintraub will also serve as acting director of FDA Center for Drug Evaluation and Research's new Division of Anti-Inflammatory, Analgesic and Dental Drug Products. Jonathan Wilkin, head of what used to be CDER's Division of Topical Drug Products, becomes director of the Division of Dermatologic and Ophthalmologic Drug Products. FDA previously announced that Debra Bowen, Medical Review Staff director, is acting director of the new Division of OTC Drug Products ("The Tan Sheet" Sept. 18, p. 1). The agency is looking for a replacement for former OTC Medical Officer Man Fung, who left in September. ODE 5 is moving to 9201 Corporate Blvd. in Rockville, Md. before the end of the year...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS084366

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel